Vytorin - News Articles

Do most people fear side effects of prescriptions & would they prefer foods or supplements?


One 2009 study was intended to examine the potential benefits of adding a second drug — either Zetia or niacin — to the treatment regime of people already taking a statin. See the Nov. 16, 2009 article, " New Study Compares the Effectiveness of Cholesterol Controlling Drugs ." That small study published in The New England Journal of Medicine compared the effectiveness of ...
logowanie - esculap


Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study). Am J Cardiol 2010, 5: 656–663. [PMID]: 20185012. Foody JM, Brown WV, ...
Who's Next? 5 Potential Biotech Takeover Targets


It would be a good fit at Pfizer to replace Lipitor sales, but I could also see AstraZeneca or Merck coming in to market it alongside Crestor or Vytorin, respectively. Vertex has already licensed its hepatitis C drug telaprevir to Johnson & Johnson, ...
إنقاص مستويات الكولسترول.. يقي من العدوى الفيروسية والسرطان | دنيا الوطن


????? ??????? ?? ?????? ?????????? ????? ?????? ????? ?? ????? ??? ??????? ??????? ????????? ???????????? ??? ????? ???? Ezteimibe (Zetia) ???? ???? ?????? ?????????? ?? ??????? ???? ??? ????? ????? ??? ??????? ??????? ??????? ??????? Angiogenesis? ??? ...
Revistas médicas "descartables" exageran ventajas de fármacos


Los investigadores, cuyo estudio apareció en la Canadian Medical Association Journal, exploraron varias revistas alemanas con artículos sobre una serie de nuevos fármacos ampliamente promocionados, como el medicamento para el colesterol de Merck Zetia (ezetimiba). Entre cinco revistas gratuitas, encontraron 253 artículos que promovían el uso de nuevos fármacos en el 2007, mientras ...
Батето кандидат-президент


Ohranitelia na Tato, Premier, zetia na Tato, Prezident!!!Neka vi e chestito!!!! ???????? ???? ? ?? ?? ?? ??????, ?? ???? ?? ?????????, ?? ???????? ????? ??????, ????????, ??????, ?????-???. . . ????? ??? ??????????, ?? ?? ?? ?????????? ??????, ...
Laboratoris rovi aumenta su beneficio un 22 en 2010 - Noticias ibex informacion ibex


Rovi lanzó en marzo de 2010, alcanzaron 3,1 millones de euros en 2010. En enero de 2011, la compañía inició la comercialización de Absorcol, cuyo principio activo es ezetimiba, y Vytorin, que combina dos principios activos, ezetimiba y simvastatina. ...
Rovi cierra 2010 con incrementos en ingresos y beneficios


Rovi espera un crecimiento de los ingresos operativos de doble dígito bajo, apoyándose para ello en motores de crecimiento tradicionales, como la 'Bemiparina' o la cartera de especialidades existente, y en lanzamientos recientes, como 'Vytorin', ...
Revistas médicas "descartables" exageran ventajas de fármacos - Público.es

elEconomista.es
Los investigadores, cuyo estudio apareció en la Canadian Medical Association Journal, exploraron varias revistas alemanas con artículos sobre una serie de nuevos fármacos ampliamente promocionados, como el medicamento para el colesterol de Merck Zetia (ezetimiba). Entre cinco revistas gratuitas, encontraron 253 artículos que promovían el uso de nuevos fármacos en el 2007, mientras ...
Zeltia - Comentarios de mercado de bolsa


Ayer Pharma Mar ?filial de Zetia, SA (ZEL -0,81% a 3060?) - comunicó que había iniciado un ensayo clínico de Fase I con su producto PM060184 en pacientes con tumores sólidos. PM060184 se convierte así en el sexto compuesto en desarrollo clínico de la cartera de productos de Pharma Mar. Los analistas de Ahorro Corporación señalan que la noticia es positiva por ampliar ...
Votreargent.fr


Parmi les principaux blockbusters, le traitement contre l'asthme Singulair a représenté un chiffre d'affaires de 1,3 milliards de dollars, en hausse de 7% et les produits anti-cholestérol Zetia et Vytorin ont généré des revenus combinés de 1,2 milliard ...
A Closer Look at ... Allergan, Merck, and Pfizer - NASDAQ.com


The pharmaceutical giant produces top prescription drugs such as asthma medication Singulair, hypertension fighters Cozaar and Hyzaar, and cholesterol combatants Vytorin, Zetia, and Zocor. The company also makes vaccines for diseases like measles, mumps, hepatitis, and shingles. Its over-the-counter offerings include Claritin allergy pills and Dr. Scholl's foot care products. From a ...
People's Pharmacy: Statins use can cause issues with memory - chicagotribune.com


Q My doctor prescribed Vytorin for high cholesterol. While my cholesterol went from over 350 to 190 in five weeks, I ended up having an eight-hour episode of transient global amnesia (TGA). I knew who I was, and I recognized my family and friends, but I didn't know the year. I ...
Aegerion appoints new chief scientific officer | TradingMarkets.com


Research at the Merck Research Laboratories, of Merck & Co. where she worked on the development of several cholesterol-reducing drug candidates, including the CETP inhibitor, anacetrapib, intended to treat hypercholesterolemia, and Vytorin. At Merck, Dr Tribble was also a member of the Cholesterol Task Force of the Merck/Schering-Plough joint venture. Aegerion's ...
Analysis: Wisdom of Merck deal may hinge on Remicade ruling | Reuters


It also gave Merck full control of blockbuster cholesterol fighter Vytorin and the immediate payoff of Remicade and Simponi overseas rights. "If they lose badly the Remicade/Simponi arbitration, and we've already written off vorapaxar, then two of the value drivers ...
Theravance Stock Poised To Rise On Succeeding Drug To GlaxoSmithKline's Advair | Markets | Minyanville.com


Other examples: AstraZeneca's (AZN) heartburn treatments Prilosec and Nexium, Merck's (MRK) cholesterol drugs Zocor and Vytorin and Forest Laboratories' ...
Market Observations | Schaeffer's Investment Research


prescription drugs such as asthma medication Singulair, hypertension fighters Cozaar and Hyzaar, and cholesterol combatants Vytorin, Zetia, and Zocor. ...
Article > Variation continues in access to NICE-approved drugs: study


used in glioblastoma multiforme: - Merck & Co's cholesterol-lowerer Zetia (ezetimib); - Pfizer's smoking cessation aid Champix (varenicline); - Genentech’s Lucentis (ranibizumab) for wet age-related macular degeneration (AMD); - Sanofi-aventis’ Lantus (insulin glargine) and Novo Nordisk’s Levemir ...
Earnings forecast: the week starting Jan. 31 2011 - New York Stock Market | Examiner.com


hypertension fighters Cozaar and Hyzaar, and cholesterol combatants Vytorin, Zetia, and Zocor. The company makes animal health pharmaceuticals also. For last 5 years, it was not outperformed analysts estimates twice in 2006 and 2009. Return on Equity (ROE) ...
Does cholesterol drug cause loss of memory?


Q. My doctor prescribed Vytorin for high cholesterol. While my cholesterol went from over 350 to 190 in five weeks, I ended up having an eight-hour episode of transient global amnesia (TGA). I knew who I was, and I recognized my family and friends, but I ...

Pages:   1   2   3   4   5   6   ...   Next

Need A Vytorin Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Vytorin Case - Submit Your Information Below

Do you need legal assistance with your Vytorin case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Vytorin Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.